PRIMARY CENTRAL NERVOUS SYSTEM (CNS) LYMPHOMA
Clinical trials for PRIMARY CENTRAL NERVOUS SYSTEM (CNS) LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY CENTRAL NERVOUS SYSTEM (CNS) LYMPHOMA trials appear
Sign up with your email to follow new studies for PRIMARY CENTRAL NERVOUS SYSTEM (CNS) LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy takes on hard-to-treat brain lymphoma in early trial
Disease control Recruiting nowThis early-phase study tests a personalized cell therapy called MB-CART19.1 for people with central nervous system lymphoma (CNSL) that has returned or not responded to prior treatments. The therapy uses the patient's own immune cells, modified to attack the cancer, and is made o…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM (CNS) LYMPHOMA
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 18, 2026 11:50 UTC
-
New cocktail aims to shrink brain tumors
Disease control Recruiting nowThis study tests a combination of five drugs (R-PMDT) in 33 people newly diagnosed with primary central nervous system lymphoma, a rare brain cancer. The goal is to see how many patients' tumors shrink or disappear after six cycles of treatment. Researchers will also track how lo…
Matched conditions: PRIMARY CENTRAL NERVOUS SYSTEM (CNS) LYMPHOMA
Phase: PHASE2 • Sponsor: Zou Dehui • Aim: Disease control
Last updated Jun 11, 2026 12:10 UTC